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Bile ductsBiliary atresia (BA) is a progressive ﬁbro-inﬂammatory pediatric liver disease in which osteopontin (OPN), a
glycoprotein with inﬂammatory and ﬁbrogenic activity, may play a pathogenic role. The current studies were
conducted in a mouse model of rotavirus-induced BA to test the hypotheses that live but not inactivated
rotavirus causes antigenemia, upregulation of hepatic OPN expression, and induction of BA and ﬁbrosis; and
that OPN is necessary for development of BA. Prolonged or transient antigenemia developed in mice
inoculated with live or inactivated virus, respectively, but only live virus upregulated hepatic OPN and caused
BA and ﬁbrosis. OPN was expressed in intra- and extrahepatic bile ducts in healthy mice and in mice with BA.
OPN-deﬁcient mice, similar toWTmice, developed BA. Together, these data show that live but not inactivated
rotavirus causes upregulation of hepatic OPN expression and BA but that OPN is not necessary for
development of BA.aylor College of Medicine, One
3633.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Biliary atresia (BA) is a serious childhood liver disease in which
ﬁbro-inﬂammatory obliteration of bile ducts results in progressive
liver damage. Fibrogenesis is notably rapid, and some infants develop
cirrhosis within months of disease onset. BA represents the most
common indication for liver transplant in children (Sokol et al., 2007).
In approximately 85% of cases, there are no other organ anomalies and
infants are born apparently healthy, but jaundice and onset of
progressive liver disease occur within the ﬁrst several weeks of life.
The cause of this “perinatal” form of biliary atresia is unknown, but it
has been hypothesized that viral infection may provide an initial
insult that triggers immune-mediated damage to intra- and extrahe-
patic bile ducts that persists even after viral infection has cleared
(Mack et al., 2005, 2006; Shivakumar et al., 2004).
Although data are contradictory, a number of viruses, including
cytomegalovirus, Epstein-Barr virus, reovirus type 3, human papillo-
mavirus, human herpesvirus 6, and group C rotavirus, have been
implicated as potential etiopathogenic agents of perinatal biliary atresia
(Domiati-Saad et al., 2000; Drut et al., 2008; Qiao et al., 1999; Mahjoub
et al., 2008; Tyler et al., 1998). In one series, group C rotavirus RNAwasidentiﬁed in 10 of 20 patients diagnosed with biliary atresia or
choledochal cyst, whereas none of 12 similarly-aged controls with
other types of liver disease had detectable rotavirus in their livers
(Riepenhoff-Talty et al., 1996).
Identiﬁcation of rotavirus in the liver tissues of BA patients indicates a
possible association between virus infection and BA, and a well-
established mouse model of rotavirus-induced BA serves as evidence
that a viral infection can initiate an inﬂammatory response that leads to
BA(Allenet al., 2007;Macket al., 2005, 2006;Nadler et al., 2009;Petersen
et al., 1997; Riepenhoff-Talty et al., 1993; Shivakumar et al., 2004). In this
model, neonatal mice inoculated intraperitoneally (ip) with rhesus
rotavirus (RV) develop infection of biliary epithelium followed by a Th1-
biased, immune-mediated bile duct damage resulting in progressive liver
disease. The clinical disease and histopathological ﬁndings in themurine
BA model closely resemble BA in human infants. Replicating virus has
been identiﬁed in liver homogenates fromRV-infectedmicewith BA, but
there are no published studies that use immunohistochemistry to
identify nonstructural viral components (such as NSP4, the presence of
which indicates viral replication) in bile ducts. The presence of RV in the
blood, or antigenemia, also requires study in the BA mouse model. RV
antigenemia is a phenomenon that has recently been demonstrated in
normal RV-infected mouse and human hosts (Blutt et al., 2006, 2007).
There are no published reports, however, investigating RV serum
antigenemia in the BA mouse model (or, for that matter, in mouse
pups inoculated at the young age of 2 days old or via the ip route).
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Fig. 1. Kinetics of development of BA inneonatalmousepups.Miceweremonitored for the
development of BA (acholic stools, bilirubinuria, and, at 14–16 dpi, extrahepatic biliary
strictures) at different times after inoculation with puriﬁed live triple-layered RRV
particles (TLP), inactivated TLP, or saline. Total number of pups evaluated in each group is
indicated above each bar. All mice that had acholic stools and bilirubinuria at 15–16 dpi
had obvious extrahepatic bile duct and gallbladder abnormalities including strictures and
dilatations, reﬂecting the speciﬁcity of objective assessment of stool and urine as a tool for
detecting BA in this model.
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Th1 cytokine activity and promote ﬁbrogenesis, both ofwhichmay play
an important role in the pathogenesis of human BA (Cantor and
Shinohara, 2009; Harada et al., 2003; Syn et al., 2010; Szalay et al., 2009;
Vetrone et al., 2009). A microarray study showed that osteopontin
mRNA expression was upregulated in liver biopsy specimens from
humanBApatients (Bezerra et al., 2002).OPNprotein is expressed in the
intrahepatic bile ducts of BA patients but not in those of healthy
children, with the intensity of osteopontin staining correlating with
severity of ﬁbrosis (Huang et al., 2008; Whitington et al., 2005). These
ﬁndings suggest that pathogenic mechanisms unique to BA, which
distinguish BA from certain other childhood liver diseases, may include
biliary upregulation of OPN expression.
Hepatic OPN expression was shown to be increased in a mouse
model of nonalcoholic steatohepatitis, and OPN-deﬁcient mice had
reduced inﬂammation and ﬁbrosis compared with WT mice in this
model (Sahai et al., 2004). OPN expression levels and patterns in the
mouse BA model have not been reported. A microarray study of the
rotavirus BA model did not report up- or down-regulation of OPN in
extrahepatic biliary tissues, but liver tissue was not examined in that
study (Carvalho et al., 2005). Here, we report use of the RV BA mouse
model and in vitro studies to determine if OPNexpression is increased in
the liver in BA, if OPN contributes to development of BA, and if
replicating RV is required to elicit antigenemia, OPN expression, and BA.
Results
Induction of BA in neonatal mice requires high doses of replicating RV
To set up the mouse model of RV-induced biliary atresia, we
intraperitoneally inoculated neonatal mice (24–48 h after birth) with
puriﬁed triple-layered rhesus RV particles. The amount of virus necessary
to cause BA in 50% of themice (the BA50) was determined to be 4.8×106
plaque forming units (pfu). This dose was signiﬁcantly higher than the
dosedetermined to cause anantibody response in50%of the animals (the
ID50), which was 553 pfu. The antibody responses in these animals
resulted from infection rather than from the ip-injected viral antigenic
load based on control experiments that evaluated the geometric mean
antibody titer (GMT)of pupsgivenequivalenthighamounts (4×107 pfu)
of puriﬁed live and inactivated virus and found a 32-fold higher titer in
animals given live virus. The GMT at the ID50 was ~9, so, extrapolating
from the data above, it would be expected that no antibody would be
detected in animals given the equivalent of the ID50 of inactivated virus.
To maximize the possibility of inducing BA with inactivated RV, a
high inoculation dose of 8.3 BA50 doses (4×107 pfu or 7.9×104 ID50
doses) was used in subsequent experiments that evaluated the time
course of development of BA, the requirement for replicating virus to
induce BA, and the effect of RV on OPN expression.
Following inoculation with either live or inactivated puriﬁed RV, BA
development was assessed in neonatal mice at 4 days post-inoculation
(dpi), 9–10 dpi, or at 15–16 dpi. At 4 dpi, three of seven pups inoculated
with live RVhadacholic stools andbilirubinuria, andno extrahepatic bile
duct abnormalitieswere visualized. All pups (N=5) inoculatedwith live
virus andassessed at 9–10 dpi had developed BA (Fig. 1), and9 of 10had
BA at 15–16 dpi. The live virus-inoculated pup that did not meet BA
criteria at 15–16 dpi had previously appeared sickly and jaundiced like
its littermates, so this puppresumably developedBAand then recovered.
By 15–16 dpi, all pups inoculated with live virus with BA were visibly
stunted, oily, jaundiced, and physically inactive compared with
inactivated virus and saline treated animals, which were all robust,
pink, and, physically active (Fig. 2a). Nopups inoculatedwith inactivated
virus (N=24) orwith saline (N=14) exhibited any of the criteria for BA
at anyof the euthanasia timepoints.At 9–10 dpi andat 15–16 dpi, all live
virus-inoculated pups that had bilirubinuria and acholic stools also had
extrahepatic bile duct strictures and/or dilatations, while none of the
saline inoculated or inactivated virus pups had bile duct strictures ordilatations (Fig. 2b). Two additional pups inoculated with live virus that
had jaundice, oily hair, and stunted growth died at 15–16 dpi, before
they could be assessed, and were excluded from the analysis.
Pups inoculatedwith live virus exhibitedmarkedly stunted growth
rates compared to inactivated virus or saline treated pups (Fig. 2c).
The average weights of live virus-inoculated pups were signiﬁcantly
lower than the average weights of saline (pb0.01) and inactivated
virus-inoculated pups (p=0.01) from 4 dpi to 15 dpi. Live RV treated
pups began to lose weight daily beginning at 12 dpi. The weights of
pups given inactivated virus were slightly but signiﬁcantly lower than
saline-inoculated pups 10 dpi through 16 dpi. Because pups inoculat-
ed with inactivated virus remained healthy and were visibly
indistinguishable from saline-inoculated pups, their slightly lower
weight is unlikely to be related to the experimental inoculation and
unlikely to be biologically signiﬁcant.
Sustained live RV antigenemia and transient inactivated RV antigenemia
develop in neonatal mouse pups inoculated ip with RV
It has been recently discovered that RV circulates systemically in
both animals and humans (Blutt et al., 2006, 2007). This ﬁnding has
important implications for how RVmight reach the biliary tract and for
its role in pathogenesis of BA. There are no studies reporting
antigenemia following inoculation of animals with inactivated RV, and
no studies of the mouse BA model investigating antigenemia. To
determine if intraperitoneal inoculation with inactivated RV can cause
antigenemia in neonatal pups, pups were inoculated with live RV,
inactivated RV, or with saline as described above, and serum was
assessed for the presence of RV antigen at 1 day, 4 days, 9–10 days, or
15–16 days post-inoculation. RV antigenwas undetectable in the serum
of all saline-inoculated mice at all time points. RV antigen was detected
in the serum of mice inoculated with live RV at all time points tested,
based on ODs being above the lower limit of detection in this ELISA
(0.094), and ODs were signiﬁcantly higher than in saline-inoculated
mice at all time points tested (pb0.01), although the mean OD at 15–
16 dpi was low (Fig. 3). RV antigen was also detected in the serum of
mice inoculated with inactivated virus at 1 dpi and not signiﬁcantly
different than in live RV treatedmice at that time, although themeanOD
was lower. Antigen levels in inactivated RV treated mice were
signiﬁcantly higher than in saline treated mice both at 1 dpi (pb0.01)
and at 4 dpi (pb0.05). These ﬁndings demonstrate that serum RV
antigenemia occurs inmice injected ipwith the equivalent of 4×107 pfu
inactivated RV up to 4 dpi.
In sum, intraperitoneal inoculation of newborn mice with a high
dose of live RV caused sustained serum antigenemia (up to 15–16 dpi),
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Fig. 2. RV-induced BA in a mouse model shares important clinical characteristics with
human BA. (a) Jaundice and stunting of live RV-inoculated mouse with BA. Mouse
inoculated with saline (S) weight 11.29 g; mouse inoculated with inactivated virus (I)
weight 10.93 g; andmouse inoculatedwith live virus (L) weight 5.23 g at 16 dpi. Mice (S)
and (I) had pigmented stools and normal urine, and mouse (L) had acholic stool, and
bilirubinuria. (b) Liver and extrahepatic biliary tree of the same pups under dissecting
microscope (~6×). Live RV-inoculated mouse liver has dark yellow hue, tortuous cystic
duct (CD), necrotic foci (arrow)anddistended,dark-coloredgallbladder (GB) secondary to
bile stasis. (c) Live RV-inoculated pups had signiﬁcantly lower average body mass
beginning at 4 dpi (pb0.01) compared with inactivated virus and saline treated pups (*).
The averagebodymass of inactivatedRV treatedpupswas slightly lower than that of saline
treated pups, but this did not reach statistical signiﬁcance until 10 dpi and after (p=0.01)
(#).
Fig. 3. Live and inactivated RV inoculated pups develop serum RV antigenemia. RV
serum antigenemia at 1, 4, 9–10, and 15–16 dpi. For saline-inoculated pups, N=16, 14,
4, 5, at 1 dpi, 4 dpi, 9–10 dpi, and 15–16 dpi, respectively. For inactivated RV-inoculated
pups, N=12, 7, 8, and 9 for the same time points. For live RV-inoculated pups, N=4, 7,
7, and 7 for the same time points. The lower limit of antigen detection (0.094) is
indicated with a thin horizontal line. (*) indicates pb0.01 vs saline treatment group. (#)
indicates pb0.05 vs saline group. Inactivated RV vs live RV at 1 dpi was NS, and
inactivated RV vs saline at 9–10 dpi and at 15–16 dpi was NS.
283P.M. Hertel et al. / Virology 417 (2011) 281–292and intraperitoneal inoculationwith the samedoseof inactivatedRV led
to transient serum antigenemia. These results indicate that virus could
be delivered to the biliary tree through the bloodstream.Replicating RV and histopathology consistent with BA are observed in
livers of mice injected with live but not inactivated RV
Infectious RV in liver extracts has been reported in themousemodel
of BA, and RV capsid proteins have been identiﬁed in the bile duct
epithelium of mice with RV-induced BA (Allen et al., 2007; Mohanty et
al., 2010; Shivakumar et al., 2004). However, immune staining for
nonstructural RV proteins, whose presence indicates replicating RV, has
not been performed in the BA mouse model. To characterizehistopathology in mice with BA and to determine if replicating RV is
localized to infected biliary epithelium in the BA mouse model, we
stained consecutive slides with hematoxylin and eosin and anti-RV or
anti-NSP4. At 4 dpi, 38 of 59 (64%) portal tracts from ﬁve mice
inoculated with live RV had portal expansion (inﬂammation), with
inﬂammatory cells distributed in a concentric fashion around bile ducts
(Fig. 4). In contrast, no inﬂamed or expanded portal tracts were
observed in either inactivated RV-inoculated mice (90 portal tracts in 4
mice) or saline-inoculated mice (43 portal tracts in 3 mice).
In animals inoculated with live RV, but not in those inoculated with
inactivated RV, viral capsid antigen-positive foci were present in 15 (25%)
of 59 portal tracts assessed in 5 mice. In corresponding areas on
consecutive sections, these RV-positive foci stained for cytokeratin 19
(CK-19), a bile duct epithelial cell marker, indicating that RVwas present
in bile ducts (Fig. 4). TheRVnonstructural protein, NSP4,was also present
inRV-positive foci onconsecutive sections, indicating that viral replication
was occurring in the infected cholangiocytes and that antigen had not
simply been deposited in the bile ducts. Therewere no RV-positive portal
tracts in inactivated RV-inoculated mice (90 portal tracts from 4 mice
examined) or in saline inoculated mice (43 portal tracts from 3 mice
examined) (pb0.01 live RV vs inactivated RV and live RV vs saline). Few
RV-positive macrophages and hepatocytes and minimal lobular inﬂam-
mation was observed in the live RV-inoculated pups at 4 dpi.
Fibrosis is an important feature in human BA, and has been described
in themouseBAmodel by approximately 2 weekspi (Nadler et al., 2009).
Picrosirius red staining, forﬁbrillar collagen,was performed on formalin-
ﬁxed sections from livers harvested at 15–16 dpi, and portal tracts were
individually assessed for the presence of ﬁbrosis (Fig. 5). Of 90 portal
tracts assessed from the livers of ﬁve mice inoculated with live RV, 72
portal tracts (80%) hadmild (nonbridging)ﬁbrosis. Therewasnoﬁbrosis,
however, in the livers ofmice inoculatedwith inactivated RV (115 portal
tracts assessed in 4mouse livers) or saline (96 portal tracts assessed in 3
mouse livers) (pb0.01 live RV vs inactivated RV and live RV vs saline).
Finally, bile ductular proliferation, a key histopathological feature of
biliary atresia, was observed in the livers of all live RV-inoculated pups
(with BA) at 15–16 dpi (N=10) but in none of thehealthypups treated
with inactivated virus (N=10) orwith saline (N=5). Proliferating bile
ductules were readily apparent using immunohistochemistry with a
CK-19 antibody (see below).
Osteopontin is expressed in all bile ducts in mice
Some studies have suggested that OPN may play a role in BA
pathogenesis in humans (Bezerra et al., 2002; Huang et al., 2008;
Anti-RV Anti-NSP4 Anti-CK19
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Fig. 4. Replicating virus is present in bile ducts of live RV-inoculated pups. Histopathology and RV, NSP4, and CK19 antigen detection in the livers of pups at 4 dpi. Bile ducts of saline
(a–c) and inactivated RV (d–f) treated mice do not stain for RV or NSP4. Liver from RV-inoculated pup shows inﬂammation surrounding foci (arrows) that stain, on consecutive
slides, for RV (g), the non-structural RV protein NSP4 (h), and cytokeratin 19 (bile ducts) (i), reﬂecting the presence of viral replication in bile ducts (20×). Insets show high-
magniﬁcation images of virus-infected bile ducts, which are also highlighted using arrows (g–i).
284 P.M. Hertel et al. / Virology 417 (2011) 281–292Whitington et al., 2005). Patterns of OPN expression have been
described in the livers and bile ducts of humans with BA in these
studies but, to our knowledge, OPN expression in the livers ofmicewith
RV-induced BA has not been described. Furthermore, previous studies
characterizing OPN expression in human and mouse liver cite conﬂict-
ing data with respect to expression in bile ducts in normal versus
pathological states, andwe sought todetermine if OPN is expressed in all
bile ducts or only in RV-infected or proliferating ducts in mice with BA
(Brown et al., 1992; Huang et al., 2008;Whitington et al., 2005; HaradaSaline Inactivat
Fig. 5. Portal ﬁbrosis is evident in mice inoculated with live RV (with BA) at 16 dpi. Health
limited to areas immediately adjacent to portal structures. The liver of a RV-injected mouseet al., 2003). To this end, we performed staining for osteopontin in
formalin-ﬁxed liver sections at early (4 dpi) and late (15–16 dpi) time
points post-infection.
Using immunoperoxidase staining for osteopontin and CK-19 (bile
duct epithelial marker) on consecutive formalin-ﬁxed sections from
livers harvested at 4 dpi, we observed osteopontin staining in areas
corresponding to infected and uninfected bile ducts, although OPN
staining was seen in slightly broader areas than CK-19 (Fig. 6a). To
determine whether OPN and CK-19 truly colocalized, frozen sectionsLive RVed RV
y inactivated RV-treated mouse and saline control mouse livers have minimal staining
at 16 dpi (20×) stained with picrosirius red shows portal ﬁbrosis (arrows).
285P.M. Hertel et al. / Virology 417 (2011) 281–292of livers harvested at 14 dpi from a separate set of mice (inoculated
with live RV) were costained for OPN and CK-19 using ﬂuorescent
secondary antibodies (Fig. 6b). Although the intensity of CK-19
staining in some cells was low, OPN and CK-19 did colocalize. This
conﬁrms that OPN was expressed in bile ducts in these specimens.
CK-19 and OPN staining on consecutive sections from 15 to 16 dpi
livers of healthy mice (inoculated with inactivated RV or with saline)
and mice with BA (inoculated with live RV) illustrated that OPN
protein was expressed in proliferating and non-proliferating intrahe-
patic bile ducts and extrahepatic bile ducts of both sick and healthy
mice (Figs. 7a–j). Cholangiocyte/bile duct proliferation occurs in
response to biliary obstruction and is a cardinal histopathological
feature of mouse and human BA (Petersen et al., 1997). We also
observed OPN expression in the epithelium of extrahepatic bile ducts
of mice with BA, including dense staining in an obstructed duct. The
staining may represent inspissated bile (OPN is secreted in bile), butAnti-RV An
Live RV
Saline
Inact RV
a
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d
g
Fig. 6. Osteopontin (OPN) is expressed in RV-infected and in uninfected bile ducts. (A) Conse
inactivated RV (d–f), or live RV (g–i) (20×). Areas of RV, CK-19 (bile duct epithelium), and O
mouse (g–i); arrows indicate RV-infected bile ducts. Normal bile ducts in saline- and in
(B) Merged immunoﬂuorescent image (yellow) on frozen liver from a live RV-inoculated m
(green), although expression in some of the CK19-positive cells is relatively weak.unlikely inﬂammatory cells, as the surrounding inﬂamed duct did not
stain (Figs. 7i and j). To further conﬁrm the speciﬁcity of the OPN
staining, sections from the liver of a 6-week-old genetically
osteopontin-deﬁcient “knockout” mouse, on a BALB/c background,
were analyzed. The bile ducts of a wild-type adult BALB/c control
mouse stained positively (Figs. 7k and l), but no staining was seen in
the bile ducts of the OPN-deﬁcient mouse (Figs. 7m and n).
Osteopontin mRNA and protein expression is upregulated in livers of
mice with BA
Bezerra et al. (2002) reported increased OPNmRNA in the livers of
patients with BA compared with normal and non-BA disease controls.
To determine if osteopontin expression is upregulated in the livers of
mice with RV-induced BA, real-time RT-PCR was performed using
RNA extracted from the livers of three groups of seven miceAnti-OPNti-CK-19
b c
e f
h i
cutive sections of formalin-ﬁxed mouse liver 4 days post-inoculation with saline (a–c),
PN staining are surrounded by dense inﬂammation in the liver of the live RV-inoculated
activated virus-treated pups also stain for osteopontin in consecutive sections (a–f).
ouse with BA at 14 dpi (20×) shows similar staining patterns for CK19 (red) and OPN
Anti-CK-19 Anti-OPN Merge
B
Fig. 6 (continued).
286 P.M. Hertel et al. / Virology 417 (2011) 281–292inoculated with 4×107 pfu live RV or inactivated RV, or saline. All live
RV-injected mice developed BA, and none of the inactivated RV or
saline inoculated mice developed BA. Osteopontin mRNA expression
was upregulated 2.3-fold in live RV-infected mouse livers compared
with the saline- or inactivated virus-inoculatedmouse livers (pb0.05)
(Fig. 8a). CK-19 was also assessed in order to determine if increased
levels of OPN mRNA in the livers of mice with BA were secondary to
increased numbers of cholangiocytes in association with cholangio-
cyte/bile duct proliferation, but CK-19 fold expression did not differ
signiﬁcantly between treatment groups. This indicates that cholan-
giocyte expression of OPN was upregulated in mice with BA, and that
increased OPN mRNA in these livers could not be accounted for solely
based on bile duct proliferation (and increased numbers of OPN-
expressing cholangiocytes). To validate mRNA ﬁndings, OPN protein
expression was assessed using Western blotting on protein extracted
from the same snap-frozen livers used above. OPN protein expression
was upregulated in livers of live RV-infected mice at 14 dpi com-
pared with inactivated RV-treated or saline-treated mice at 14 dpi
(Fig. 8b).
Rotavirus increases OPN expression in mouse cholangiocytes in vitro
RV infection of HT-29 intestinal epithelial cells causes upregulation
of OPN expression and secretion in vitro (Rollo et al., 2005). To
determine if RV increases OPN expression in cholangiocytes, immor-
talized BALB/c cholangiocytes were infected with RV, and OPN protein
expression was assessed in cell lysates at 8, 24, or 48 h post-infection
using Western blotting. OPN was slightly (i.e. 1.1 to 1.2 times) more
abundant in RV-infected than in mock-infected cholangiocyte lysates,
and densitometry analysis of immunoblots run using lysates from
triplicate wells showed statistical signiﬁcance at the 8 h time point
(data not shown).
Osteopontin is not required for development of BA in rotavirus-infected
neonatal mice
To determine if OPN is necessary for development of BA in the
rotavirusmousemodel, WT and genetically OPN-deﬁcient (OPN−/−)
2-day-old Balb/c mouse pups were inoculated ip with 4×107 pfu RV
(as above) or saline and assessed for BA, deﬁned as acholic stools and
bilirubinuria, beginning at 5–6 dpi.
Thenumber of days of survival post-inoculationwas also recordedup
to 17 dpi. Days of survival pi for RV-injectedWTmice were signiﬁcantly
more numerous than for RV-injected OPN−/−mice (pb0.001) (Fig. 9a).
AllWT (N=14) andosteopontin-deﬁcient (N=10)mice inoculated
withRVdevelopedbilirubinuria and/or acholic stools by5–8 dayspi (NS
WT versus OPN-deﬁcient RV-infected) (Fig. 9b). Injecting a lower dose
of RV, 5.2×106 pfu, resulted in a slightly lower frequency of BA in both
WT and OPN-deﬁcient mice, but, again, there was no signiﬁcantdifference in OPN-deﬁcient and WT rates of BA. None of the mice
inoculated with saline (N=10 and N=8 for WT and osteopontin-
deﬁcient, respectively) developed bilirubinuria or acholic stools (saline-
treated mouse BA data not shown).
WT and OPN-deﬁcient mice treated with 5.2×106 pfu RV or saline
were also assessed at 10 dpi for morphological abnormalities in the
extrahepatic biliary tree under a dissectingmicroscope, and livers were
then harvested for histopathological assessment. All WT RV-treated
pups with acholic stools and bilirubinuria also had morphologic
abnormalities of the extrahepatic biliary tree indicating extrahepatic
biliary obstruction including distended gallbladders ﬁlled with darkly-
colored bile and/or stones, and 3 of these pups also exhibited an
irregular appearance to the common bile duct consistent with early
development of strictures and/or dilatations. Among RV-treated
osteopontin-deﬁcient mice, 10 had an abnormal appearance to the
gallbladder and three of these also had tortuous cystic ducts as seen in
the WT mice with BA described earlier in this manuscript. Thus, at
10 dpi, there was evidence of cholestasis and extrahepatic biliary tree
abnormalities in both WT and OPN-deﬁcient RV-treated mice, and
there were no distinguishable differences in rates of BA or extrahepatic
biliary tree morphology between RV-infected WT and OPN-deﬁcient
mice.Discussion
Ournovelﬁndings in the RVBAmousemodel includedemonstration
that: (1) the dose of virus required to elicit BA is much greater than the
dose required to infect neonatal pups; (2) transient RV antigenemia but
not BA occurs following ip inoculation with inactivated RV. Also,
protracted RV antigenemia,more persistent than previously reported in
mice, occurs following inoculation with live RV; (3) RV replicates in
cholangiocytes as evidenced by presence of the NSP4 in these cells;
(4) hepatic osteopontinmRNA and protein expression is upregulated in
micewith BA, which reﬂects ﬁndings in the livers of human BApatients,
(5) OPN protein expression is modestly elevated in RV-infected
cholangiocytes in vitro, and (6) osteopontin protein is expressed
constitutively in all intrahepatic and extrahepatic bile ducts in normal
(and diseased) mice.
Previous studies using the neonatal mouse model of BA inoculated
mouse pups at 12–24 h of age with doses of RRV that ranged from
4×104 pfu to 1.5×106 ffu. Notably, these previous studies inoculated
with a lower dose of virus and a younger age than we did and reported
development of BA in ~60% to 80% of pups, respectively (Mack et al.,
2005; Shivakumaret al., 2004).Higher rates of BAandmortalityusingan
earlier inoculation age have clearly been demonstrated in this model
previously (Czech-Schmidt et al., 2001). In our studies, we inoculated
slightly older animals (24–48 h of age) to facilitate handling and
determined that the dose of puriﬁed RRV administered by IP injection
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infect these mice based on induction of an antibody response.
No previous studies determined or compared the BA50 to the ID50 in
this model, and the large difference in the BA50 compared to the ID50
(~104 fold higher) is remarkable. Although it remains unclear why such
a high dose is needed, perhaps a large number of cholangiocytes in the
liver need to be infected to trigger the cascade of immune-mediated
events that cause BA in this mouse model while much smaller doses of
virus can elicit a robust antibody response. This might indicate that
cholangiocytes are somewhat resistant to infection but this restriction
can be overcome by large doses of virus. Shivakumar et al. (2004)
determined that the titer of RRV required to infect immortalized BALB/c
mouse cholangiocytes in culture was 100 times higher than in MA104
cells (monkey kidney cell line, readily infected by rhesus RV). This
relative resistance could also be a factor in the age-dependence of BA,
with cholangiocytes from younger animals beingmore susceptible; this
might explain why older mice do not get BA when given high doses of
the same virus.
Our studies show that RV administered ip enters the circulation and
virus antigen was detectable in serum at 25 hpi, the earliest time point
examined. Antigenemia occurred whether the virus inoculated was live
or inactivated. The initial systemic distributionof injectedRVmost likely
occurred as a result of the virus passing directly into the vasculature
from the peritoneum. The augmented and sustained antigenemia
uniquely observed with live RV, however, was most likely supported
by ongoing supply of new RV particles from infected epithelium
(intestinal, biliary). Because natural RV infection begins in the intestine,
it is possible that virus traveling through the bloodstream is an
important mechanism by which RV is delivered to the biliary tree
from the intestine. Lack of development of any feature of BA following
injection with inactivated RV, despite transient antigenemia, indicates
that replication of live RV in bile ducts is required to trigger the cascade
of inﬂammatory events that leads to the bile duct destruction and
progressive liver disease seen in thismodel. Although Shawet al. (1995)reported that oral inoculation of 8- to 9-day-old mice with 1.5×106 ffu
of inactivated RV caused mild diarrhea, we did not observe diarrhea or
any other obvious sign of disease in neonatal mice inoculated ip with
inactivated RV. Diarrhea is inconsistently seen in our neonatal mice
inoculated with live RV, however, so lack of diarrhea with inactivated
virus may not be surprising in this model.
While mice inoculated with inactivated RV did not develop biliary
atresia, they had mild stunting of growth. There are several possible
explanations for this observation. First, andmost likely, there may have
been anunequal sex distributionof pups betweengroups (males tend to
weigh more than females as mice grow older); unfortunately, this was
only considered after the datawere analyzed, and sexwas not able to be
determined retrospectively. Secondly, the presence of serum antigene-
mia suggests that the inactivated virus particles circulated systemically
and could theoretically have causedmild disease in any organ, affecting
ponderal growth.
The feature of portal inﬂammation and ﬁbrosis in our studies
prompted us to examine expression of osteopontin in this BA mouse
model because osteopontin plays roles in both inﬂammation and in
ﬁbrosis, and because it appears that it may contribute to BA
pathogenesis in humans (Bezerra et al., 2002; Huang et al., 2008;
Whitington et al., 2005). To our knowledge, hepatic osteopontin
expression has not previously been studied in the BA mouse model.
We have demonstrated that inoculation of neonatal mice with live RV
leads to BA and upregulation of OPN expression concurrent with portal
ﬁbrosis, reﬂectingﬁndings in livers of human BApatients (Bezerra et al.,
2002; Huang et al., 2008; Whitington et al., 2005).
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roles in inﬂammation and ﬁbrogenesis in numerous disease models
(Cantor and Shinohara, 2009; Harada et al., 2003; Szalay et al., 2009;
Vetrone et al., 2009) and could promote inﬂammation and/or
ﬁbrogenesis in BA. Our ﬁnding that osteopontin is expressed not
only in proliferating bile ducts but also in normal intrahepatic bile
ducts differs from ﬁndings in two studies of OPN expression in human
BA in which, using different anti-OPN antibodies than the one we
used, OPN was observed in proliferating bile ducts in non-syndromic
BA but not in intrahepatic bile ducts of normal or disease controls
(Huang et al., 2008; Whitington et al., 2005). One study, also using a
different antibody than the antibody used in our experiments,
described weak OPN protein expression in bile ducts of primary
biliary cirrhosis patients but strong mRNA using in-situ hybridization
(Harada et al., 2003). In an extensive survey of OPN expression in
numerous human tissues, Brown et al. (1992) reported the presence
of OPN mRNA in liver and gallbladder, localized to epithelia in both
tissue types using immunohistochemistry and (in gallbladder epithe-
lium) in-situ hybridization.
Other studies using mouse or human tissues have reported variable
OPN staining patterns in the liver and bile ducts depending on which
antibodywasused (Fickert et al., 2007;Nakai et al., 2008).DifferentOPN
antibodies may show apparently different expression patterns in the
liver because OPN undergoes considerable post-translational modiﬁca-
tion, and antibodies made to OPN may bind to different OPN epitopes
depending on the degree of post-translational modiﬁcation of OPN
when the antibodywasmade. Consistent with our ﬁndings, others have
shown expression of osteopontin in normal intrahepatic mouse bile
ducts using the antibody we used (Fickert et al., 2007), and lack of bile
duct staining in a genetically osteopontin-deﬁcientmouse in our studies
conﬁrms speciﬁcity of this antibody. We also observed OPN staining of
occasional inﬂammatory cells identiﬁed morphologically in RV-treated
mice, but havenot characterized thisﬁnding further.OPN is known tobe
expressed by several types of inﬂammatory cells (Whitington et al.,
2005).
We were able to demonstrate a modest upregulation of OPN
expression in RV-infected cholangiocytes in vitro under the conditions
we tested, and the vast majority of OPN-expressing cells in the liver are
cholangiocytes. It is likely that upregulated expression in cholangiocytes
accounts for the increased hepatic OPN we observed in mice with BA,
but perhaps OPN expression is more highly upregulated in cholangio-
cytes in vivo than in vitro because indirect effects of RV infection are
operative in the liver, such as a cytokine or chemokine-mediated effects.
IFN-γ is a highly upregulated cytokine in the livers of mice with BA and
an important mediator of bile duct obstruction in this model
(Shivakumar et al., 2004). Barnes et al. (2008) observed that incubation
of immortalized BALB/c cholangiocytes with IFN-γ induced expression
of a broader spectrum of cytokines and chemokines, including IL-6 and
TGF-β, than incubation with RV. IFN-γ induces OPN expression in
monocytoid cells (X. Li et al., 2003; Z. Li et al., 2003). It is thus possible
that IFN-γ stimulates cholangiocytes to increase OPN expression in vivo.
This is a question that merits further investigation.
In considering the data we present here along with previously
reported ﬁndings, OPN is apparently upregulated only in intrahepatic,
but not extrahepatic, biliary epithelium in the RV mouse model of BA
(human extrahepatic bile ducts have not been studied) (Carvalho et al.,
2005). It is thus possible that OPN is speciﬁcally upregulated in
proliferating bile ducts, which are located only within the liver. Several
types of proliferating cells may have increased expression of OPN (De
Barros et al., 2010; Sun et al., 2009; Whitington et al., 2005).
Alternatively, upregulation of OPN in intrahepatic and not extrahepatic
cholangiocytes could potentially result from any of a multitude of liver-
speciﬁc factors that extrahepatic bile ducts are not exposed to. The
milieu of the liver differs signiﬁcantly from that of the extrahepatic
biliary tree, with the presence of hepatocytes, resident Kupffer cells, and
other cell types that contribute to the immune response (Racanelli andRehermann, 2006). Furthermore, cholangiocytes of the intrahepatic bile
ducts differmorphologically and functionally fromcholangiocytes of the
extrahepatic bile ducts, and have different transcriptional proﬁles
(Glaser et al., 2010). Each of these differential features of the liver and
extrahepatic bile ducts could help to explain differences in intrahepatic
versus extrahepatic biliary OPN expression in BA, and should be
examined in future studies focusing on BA pathogenesis.
Because OPN has Th1 cytokine activity and a Th1 response to RV
infection of cholangiocytes leads to BA in the mouse model, we were
surprised to discover that it is not critical for disease (Mack et al., 2005;
Shivakumar et al., 2004). Because inﬂammation involves redundant
pathways, a compensatory response to RV infection and bile duct
obstruction in OPN-deﬁcient mice may be occurring. OPN may thus be
contributory in disease pathogenesis in this model, but we have shown
that it is not critical. In a DDC-induced mouse model of primary
sclerosing cholangitis, an obstructive cholangiopathy (like BA is), it was
found thatOPN-deﬁcientmice had similar degrees of disease severity as
WT mice in several aspects, including degree of inﬂammation and
ﬁbrosis, indicating that OPN is not critical for disease in this model,
either (Fickert et al., 2010). OPN is also not critical for disease in carbon
tetrachloride-induced hepatocellular toxicity and, in fact, OPN-deﬁcient
mice havemore severe necrosis and ﬁbrosis thanWTmice in thismodel
(Lorena et al., 2006). In a nonalcoholic steatohepatitis (NASH) mouse
model, however, OPN appears to play a protective role (Sahai et al.,
2004). OPN-deﬁcient mice had less severe inﬂammation and ﬁbrosis
despite similar degrees of steatosis in this study. Interestingly, an anti-
TNF agent also reduced inﬂammation in this model, in which TNF-α
expression is upregulated, whereas anti-TNF treatment had no
beneﬁcial effect on disease in the BA mouse model, in which TNF-α is
also upregulated (X. Li et al., 2003; Z. Li et al., 2003; Mack et al., 2005).
Further dissection of the immune responses in each of these disease
models is required to elucidate pathways that are distinct in each and to
provide some explanation for why inhibition of OPN and of TNF-α have
distinct effects.
Conclusions
In conclusion, we report novel ﬁndings in an established mouse
model of RV-induced BA that shed new light on viral pathogenesis and
on thepotential role ofOPN, amoleculewithpro-inﬂammatory andpro-
ﬁbrogenic activity that potentially plays a role in pathogenesis of human
BA. For the ﬁrst time, we report that inactivated RV serum antigenemia,
which, despite implications for delivery of inactivated RV to the liver,
does not lead to BA. We have shown that high doses of replicating RV,
well above doses required to elicit a humoral immune response, are
required to elicit BA in this model, and that NSP4 is expressed in
cholangiocytes of animals with BA, providing evidence of RV replication
in these cells.Wehave shownthatOPN is constitutively expressed in the
intra- and extra-hepatic bile ducts of normal mice as well as in the bile
ducts of micewith BA, a ﬁnding that has not been consistently reported
in the literature orwidely acknowledged.We also report increased OPN
expression in the livers ofmicewith BA, as has been previously reported
in the livers of human BA patients, which is most likely secondary to
increased production on OPN by cholangiocytes in affected mice.
Although we observed only slightly increased OPN upregulation in RV-
infected cultured cholangiocytes, it is likely that additional factors
present in the livers of diseased mice indirectly cause increased OPN
production. Finally,we show, for theﬁrst time, thatOPN is not necessary
for development of BA in the RV mouse model and, in fact, hastens
mortality. The shortened life span we observed in OPN-deﬁcient RV-
infected mice may be related to direct effects of RV pathogenesis, as
opposed to immune-mediated liver damage, since OPN functions as a
cytokine and appears to be protective in a RV diarrhea model (Rollo et
al., 2005). This needs to be examined further. Because inﬂammation
appears to be critical for disease in this model (Shivakumar et al., 2004),
and because ﬁbrosis also occurs and is severe in humans with BA,
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OPN need to be examined. Further studies in the BA mouse model as
well as in DDC cholangitis and NASH mouse models could provide
valuable insight.
Materials and methods
Viruses
The simian rhesus RV (RRV) (P5[3], G3, isolated from the feces of a
3.5-month-old rhesusmonkeywith diarrhea)was kindly supplied byH.
B. Greenberg (Stanford University Medical School, Palo Alto, CA) and
was cultivated in African green monkey kidney cells (MA104) in the
presence of trypsin as described previously (Crawford et al., 2001).
Triple layered RRV particles were puriﬁed using CsCl density gradient
centrifugation, and titration of puriﬁed virus was determined by plaque
assay (Estes et al., 1979). An aliquot of puriﬁed virus was then used
to prepare psoralen-inactivated virus (PI-RRV) by incubation with 4′-
aminomethyl-4,5′,8-trimethyl psoralen (40 μg/ml for 40 min on ice
under A365 UV light) (Groene and Shaw, 1992). Inactivation of viruswas
conﬁrmed by 3 sequential passages inMA104 cells for 24 h each. Media
collected from each passage were tested for infectious virus by plaque
assay, and noplaqueswere detected fromanyof the samples. A separate
aliquot of PI-RRV was prepared for use in a separate experiment
whereby frozen liverswere obtained at 14 dpi to assess OPNexpression.
Performance of a plaque assay determined that the titer of live virus in
this aliquot of PI-RRV was b5×104 pfu/ml. The concentrations of both
aliquots of antigenically intact psoralen-inactivated virus particles were
determined to be comparable to the stock of live virus fromwhich they
were taken using a hemagglutination assay as described previously
(Kalica et al., 1978).
Animal inoculations
Newborn BALB/cWT or OPN-deﬁcientmouse pups (the latter kindly
donated by Dr. Harvey Cantor, Harvard University) were inoculated
intraperitoneally (ip) at 24 to48 hof lifewith4×107 pfu liveRRV triple-
layered particles suspended in 40 μl Tris sodium chloride-10 mM CaCl2
(TNC; hereafter “saline”); with an equivalent amount of antigenically
intact (conﬁrmed by hemagglutination assay), psoralen/UV inactivated
RRV triple-layered particles suspended in saline; or with saline lacking
virus (control animals). RV dosewas 4×107 pfu in all experimentswith
the exception of the experiment where OPN-deﬁcient and WT mice
were assessed and euthanized at 10 dpi; RV dose in this case was
5.2×106 pfu. All inoculations were 40 μl in volume, administered using
a 1 cm3 syringe with a 33G, 1/2 cm needle using a repeating dispenser
(Hamilton Company, Reno, NV).
Assessment for biliary atresia
Beginning at 4–5 days post inoculation (dpi), all mouse pups were
assessed daily for signs of cholestasis in the following order: animals
inoculated with PBS, animals inoculated with inactivated virus and,
lastly, animals inoculated with live virus. The weight in grams, to two
decimalpoints, of all pups in each litter (allowing for calculation ofmean
pup weight for each litter) was recorded on the day of inoculation and,
beginning at 3 dpi, theweight of each individual pupwas recorded daily
until thepupdied orwaseuthanized. Stool andurinewere elicitedwhen
possible by gently palpating the abdomen. Stool color was assessed by
colorimetric scale using a paint color swatch RC11 (Glidden/ICI Paints,
Cleveland, OH). Acholic stool was deﬁned as stool color 1 (Wood Lily,
40YY 83/129), stool color 2 (Corn Silk, 40YY 77/242), or stool color 3
(Sweet Corn, 30YY 58/423). Stool color 4 (Golden Marguerites, 20YY
37/654)was deﬁned as not acholic (i.e. normal). Urinewas assessed for
direct bilirubin content using the bilirubin index on a rapid Multistix
dipstick test per package instructions (Bayer Corporation, Elkhart, IN).Bilirubinuriawasdeﬁnedashigh (+++)urinebilirubin content. Biliary
atresiawas deﬁned as presence of acholic stool and bilirubinuria at time
of euthanasia and, in mice euthanized at the 14–16 dpi time point,
visible extrahepatic biliary tree strictures, dilatations, and/or cystic duct
tortuosity as viewed under the dissecting microscope ~6× (described
below). All 9 mice examined at 14–16 dpi that had bilirubinuria and
acholic stools had obvious extrahepatic biliary dysmorphology, reﬂect-
ing the speciﬁcityof objective stool andurineassessmentalone todeﬁne
BA in this model.
Serum and tissue sample collection and processing
At 4, 9–10, or 15–16 days post-inoculation (dpi), each pup was
anesthetized with isoﬂurane and decapitated. Blood from the neck
vessels was placed in a plasma separator tube (Becton Dickinson and
Company, Franklin Lakes, NJ). The tube was centrifuged at 10,000 rpm
for 5 min, and the serumwas stored in a separate microcentrifuge tube
at 4 °C pending analysis. The abdomen and chest were opened with a
single longitudinal incision, and the extrahepatic bile ducts, gallbladder,
and liver were examined under a dissecting microscope (6×).
Extrahepatic bile duct and cystic duct gross morphology was described
by noting the presence or absence of marked tortuosity, strictures, and/
or cystic dilatations. The liver and extrahepatic bile ducts were then
removed by ﬁrst resecting the anterior lobes and then the remainder of
the liver, extrahepatic bile ducts and a small portion of duodenum was
removed en block (4 dpi or 9–10 dpi), or in a similar fashion without
ﬁrst resecting theanterior lobes (15–16 dpi). Tissueswere allowed toﬁx
in 10% neutral-buffered formalin overnight and then stored in 70%
ethanol for dehydration until parafﬁn embedding and sectioning was
performed (below). In some experiments designed to allow perfor-
mance of ﬂuorescent immunohistochemistry and qRT-PCR on frozen
livers, livers were harvested and snap frozen using liquid nitrogen.
Evaluation of histology and immunohistochemistry
To evaluate histopathology, formalin-ﬁxed, parafﬁn-embedded
sections were stained with TROMA III rat anti-cytokeratin 19 (CK19)
(Developmental Studies Hybridoma Bank, Iowa City, IA), rabbit anti-RV
serummade against lapine RV strain ALA (Blutt et al., 2007), rabbit anti-
NSP4 peptide 114–135, or goat anti-mouse osteopontin (R&D Systems,
Minneapolis, MN). The Vectastain Elite ABC kit (Vector Laboratories,
Burlingame, CA) and liquid 3,3′-diaminobenzidine (BioGenex, San
Ramon, CA) were used as recommended by the manufacturer. Staining
for CK19, RV, and osteopontin was performed on consecutive sections
from eachmouse liver. NSP4 (nonstructural RV protein) and picrosirius
red (ﬁbrillar collagen staining for ﬁbrosis; Polysciences, Inc., Warring-
ton, PA) staining was performed on nonconsecutive and on a few
consecutive sections. Immunoﬂuorescent co-stainingwasperformedon
snap-frozen liver sections harvested at 14 dpi (see above) using TROMA
III anti-CK19 and anti-osteopontin primary antibodies followed by
secondary Alexa-Fluor (Invitrogen, Carlsbad, CA).
Determination of ID50 and BA50
BALB/c mouse pups at 24–48 h of age were inoculated intraperito-
neally with 40 μl of 10-fold serial dilutions of rhesus RV live puriﬁed
triple layered particles. Each dose was given to 4–10 pups. At 14 dpi,
pups were evaluated for BA, as described above, then euthanized and
serum collected to detect RV-speciﬁc antibody by ELISA. The ID50,
deﬁned as the dose required to induce detectable (i.e. a titer of 50 or
higher) anti-RV serum antibody in 50% of pups, and the BA50, deﬁned as
the dose required to induce acholic stool, bilirubinuria, and visible
strictures or dilatations (at 6×) of extrahepatic bile ducts in 50% of mice
were calculated by the method of Reed and Muench, as described
previously (Reed and Muench, 1938).
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ELISA was performed in 96-well polyvinyl chloride microtiter plates
(Dynatech, McLean, VA). The plates were coated with guinea pig serum
(diluted 1:5000 in carbonate bicarbonate buffer pH 9.6) containing anti-
SA11 RV antibody, blockedwith blotto (5% [wt/vol] Carnation powdered
milk in PBS) and washed. SA11 RV was added in a concentration
necessary to obtain a standard titer of the positive control rabbit serum
and1/10blottowas addedas anegative antigencontrol for eachwell. The
plates were incubated at 37 °C for 1 h and washed, then test samples
were added serially diluted twofold down the plate and incubated again
for an hour. After anotherwash, horseradish peroxidase-conjugated goat
anti-rabbit IgA, IgM, and IgG (Kirkegaard and Perry Laboratories,
Gaithersburg, MD) were added at a concentration of 1:10,000 with 5%
normal guineapig serum, incubated for anhour, andplateswerewashed.
TMB Micro-well ELISA substrate (Kirkegaard and Perry Laboratories,
Gaithersburg, MD) was added and allowed to react for 10 min at room
temperature, and the reaction was stopped by the addition of an
equivalent volume of 1 MH3PO4. Optical densities (ODs) at 450 nmwere
determined with a SpectraMax M5 microplate reader (Molecular
Devices, Sunnyvale, CA). A sample was considered positive if the
OD450 value of the virus well minus the control well was greater than
0.1. Additionally, an endpoint titer of the positive control serum (run on
each plate) had to be within two dilutions of an established standard for
the test to be acceptable. Antibody titer for each sample was deﬁned as
the inverse of the lowest dilution that tested positively, and detectable
antibody was considered present in samples with titers of 50 or greater.
Detection of RV antigen by ELISA
Serum samples were evaluated for the presence of RV antigen by
ELISA. ELISAs were performed in 96-well polyvinyl chloride microtiter
plates (Dynatech, McLean, VA). The plates were coated with mouse
ascites (diluted 1:20,000 in carbonate bicarbonate buffer pH 9.6)
containinganti-VP66E7monoclonal antibody in carbonate–bicarbonate
buffer (pH 9.6) and incubated overnight at room temperature. The
plates were blocked with 200 μl of 5% blotto (5% [wt/vol] Carnation
powderedmilk in PBS) for 2 h at 37 °C. Following removal of the blotto,
the plates were washed three times with 0.05% Tween 20 in PBS. The
serum samples, in 20 μl aliquots, were treated with 50 mM EDTA.
Hyperimmune guinea pig serum to SA11 RV diluted (1:2000) in 1/10
blotto was used as the detector antibody. Horseradish peroxidase-
conjugated goat anti-guinea pig immunoglobulin G (Sigma) diluted
(1:1000) in 1/10 blotto with 2.5% fetal calf serum was used as the
conjugate. TMB Micro-well ELISA substrate (Kirkegaard and Perry
Laboratories, Gaithersburg, MD) was added and allowed to react for
10 min at room temperature, and the reaction was stopped by the
addition of an equivalent volume of 1 M H3PO4. Optical densities (ODs)
at 450 nm were determined with a SpectraMax M5 microplate reader
(MolecularDevices, Sunnyvale, CA).A cutoff value fordetectable antigen
was deﬁned as greater than or equal to the mean of the ODs of the PBS
control animal samples plus 3 standard deviations.
RV infection of immortalized cholangiocytes
Media containing RRV (at anMOI of 50,which is the equivalent of 50
virus particles per cell, as used previously in this cell line) (Barnes et al.,
2008; Jafri et al., 2009), or virus-free media were incubated for 1 h with
conﬂuent murine cholangiocytes, a cell line derived from WT Balb/c
mice (Mano et al., 1998). Thereafter, cells were incubated with virus-
free medium for predetermined time intervals. Media were then
aspirated and cells were treated with ice cold PBS and lysed for total
protein extraction using 50 mM Tris buffer, pH 7.5, containing 2 mM
EDTA and EGTA, 0.5 M NaCl, 1% Triton-X 100, 0.25% DOC, and protease
inhibitors. The experiment was performed in triplicate and blots were
analyzed using densitometry.Immunoblot analysis
Cell lysates from RV-infected or mock-infected BALB/c cholangio-
cytes were mixed with SDS-PAGE sample buffer, boiled for 5 min, and
loaded onto 12 or 12.5% polyacrylamide gels (BioRad). Protein from cell
culturemedia was concentrated using Vivaspin 10,000MWCO columns
(Sartorius Stedim Biotech, Goettingen, Germany) prior to loading onto
polyacrylamide gels. Flash-frozen mouse liver (14 dpi) was homoge-
nized in lysis buffer and quantity of total protein was determined using
the BCA protein assay method (Pierce, Rockford, IL) before loading
100 μg of each sample onto a polyacrylamide gel as above. After each gel
electrophoresis was complete, protein samples were transferred onto
nitrocellulosemembranes (GEHealthcare Bio-Sciences Corp., Piscataway,
NJ) as previously described (Zhang et al., 2000). Membranes were
blocked using 5% Carnation Instant Milk in PBS (Blotto) for 10 min with
agitation at room temperature. Proteins were detected with antibodies
against recombinant mouse osteopontin (R&D Systems, Minneapolis,
MN) at a dilution of 1:10,000 1:250, rat cytokeratin 19 (Developmental
Studies Hybridoma Bank, Iowa City, IA) at a dilution of 1:250, or GAPDH
(Abcam, Philadelphia, PA) at a dilution of 1:5000 in 0.5% blotto. Alkaline
phosphatase or horseradish peroxidase-conjugated secondary antibodies
(Sigma-Aldrich, St. Louis, MO) were used at a dilution of 1:3000 in 0.5%
blotto. Membranes were incubated with the primary antibodies at room
temperature overnight, washed 3 times for 5 min in 0.5% blotto, and
incubated with the secondary antibodies for approximately 2 h. The
membraneswere againwashed 3 times for 5 min in 0.5% blotto andwere
developed using alkaline phosphatase detection solution (50 mM Tris,
3 mMMgCl2, 0.1 mg/ml p-nitro blue tetrazolium chloride, and 0.05 mg/
ml 5-bromo-4-chloro-3-indolyl phosphate).
Quantitation of osteopontin and CK-19 mRNA
Levels of osteopontin mRNA expression in RV or saline inoculated
animals were determined in livers harvested and snap frozen at 14 dpi.
RNAwas extracted from a portion of each liver using RNEasy kit (Qiagen,
Valencia, CA) according to the manufacturer's instructions, and extracts
were treatedwithDNAse. cDNAwas synthesizedusing theHighCapacity
cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA)
according to themanufacturer's instructions. Real-time RT-PCRwas then
performed using SYBR green Master Mix (Applied Biosystems, Carlsbad,
CA)with 2 μg cDNA and 100 μMeach primer (OPN Fwd: 5′-ACA CTT TCA
CTCCAATCGTCC-3′; Rev: 5′-TGCCCTTTCCGTTGTTGTCC-3′, CK19 Fwd:
5′-CTCGGATTGAGGAGCTGAAC-3′; Rev: 5′-TCACGCTCTGGATCTGTGAC-
3′). The RNA isolation protocol included DNAse treatment to remove
contamination of genomic DNA. Moreover, RT-PCR sense and antisense
primerswere designed so that target sequences span across intron–exon
junctions ensuring ampliﬁcation of mRNA and not DNA. Results were
normalized toβ-actin (primers: Fwd5′-CCTTGCAGCTCCTTCGTTGC-3′;
Rev 5′-ACG ATG GAG GGG AAT ACA GC-3′).
Statistical analysis
Student's t-test was used to compare serum antigen levels, daily
weights, and osteopontin and CK-19 mRNA expression. Statistically
signiﬁcant differences between treatment groups in terms of
frequency of biliary atresia, RV in portal tracts, portal inﬂammation,
and portal ﬁbrosis were determined using a z-test for comparison of
two proportions. Kaplan–Meier survival analysis was performed using
Graphpad Prism software (San Diego, CA).
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